Rose Ventures

Investment Team

Stan Rose, Ph.D. — President and Managing Partner

Stan Rose is a Ph.D. biologist, seasoned biotechnology executive, and serial entrepreneur. He has spent over two decades working with leading scientists and clinicians to create substantial commercial value from inventions based on genome technology.  Dr. Rose is a co-founder, President and CEO of Transplant Genomics Inc., which is his primary professional focus.  Highlights from his career include serving as CEO of NimbleGen Systems, a microarray products company, from 2003 through its acquisition by Roche in 2007; co-founding and growing Genetic MicroSystems, a microarray instrumentation company that was acquired by Affymetrix in 2000; and directing the PCR business for Perkin-Elmer and Applied Biosystems during its most dynamic growth phase in the 1990s.  Since 2008 Dr. Rose has served as President of Rose Ventures, a firm that provides consulting and directing to select clients in the life science research products space, and manages a portfolio of public and private equity investments.  Dr. Rose was a Director of Cellular Dynamics International, acquired by FujiFilm in 2015, and Chair of the Market Advisory Board for Cyvek, acquired by Bio-Techne in 2014.  He currently serves on the Boards of Directors of Transplant Genomics, Nabsys, and Inverna, and as a member of SerumDPT LLC.  Dr. Rose received his B.A. from Cornell University and his Ph.D. from the Massachusetts Institute of Technology.